Form 4: Ionis Pharmaceuticals Director Allene M. Diaz Executes Stock Sales and RSU Vesting

Director Allene M. Diaz of Ionis Pharmaceuticals executed stock sales and RSU vesting, resulting in changes to her beneficial ownership.

Summary

• On July 15, 2024, Allene M. Diaz, a director of Ionis Pharmaceuticals, vested 4,677 shares of common stock from Restricted Stock Units (RSUs).
• Following the vesting, Diaz sold 900 shares on July 16, 2024, at a weighted average price of $48.9379, with prices ranging from $48.745 to $49.461.
• Additionally, 737 shares were sold on the same day at a weighted average price of $50.17, with prices ranging from $50.0825 to $50.245.
• After these transactions, Diaz beneficially owns 15,716 shares of Ionis Pharmaceuticals common stock and 4,079 Restricted Stock Units.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports stock transactions by a company director under a pre-existing trading plan. There is no indication of positive or negative implications for the company.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider and provides transparency to the market regarding the director's holdings and trading activities.

Stakeholder Impact

• The stock sales may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely minimal given the relatively small volume of shares sold.

Key Dates